Optics
← Today's headlines

3 sources checked · Left, Center, and Right included · 46m ago

Mostly Same

Thyroid medication recall upgraded to FDA's highest risk level

All headlines are identical, showing no framing differences across the various news sources.

1 Left1 Center1 Right
Same story. Mostly aligned wording. Outlets across the spectrum framed this event in roughly the same way today.

MOSTLY SAME

As of September 24, 2026 at 3:19 PM, this is how Optics News reads the wording differences in this story.

What happened The Class I categorization raises the recall to the FDA's highest risk level, indicating serious health effects or death.
The headline split The headlines are mostly aligned. The differences are small wording choices, not a major framing split.
Match confidence High confidence. 3 sources checked, Left/Center/Right all represented. Best read as a clear framing signal — not a fact-check.
Same-event confidenceMedium

3 sources across 3 bias buckets agree on the event.

Framing confidenceMostly same

0/99 — the outlets mostly agree on the headline takeaway.

WHAT EACH SIDE EMPHASIZED

Left / center-leftFDA upgraded a recalled thyroid tablet to its most dangerous recall category

Quartz · Center-left · News report

CenterThyroid medication recall upgraded to FDA's highest risk level

WBIR10 (Tegna, Knoxville) · Center · News report

Right / center-rightFDA Raises Thyroid Tablet Recall to Most Serious Level Over Superpotency Issue

The Epoch Times · Right · News report

SEE THE HEADLINES

CenterHigh
WBIR10 (Tegna, Knoxville)News report · Sep 24, 3:19 PM

Thyroid medication recall upgraded to FDA's highest risk level

The Class I categorization raises the recall to the FDA's highest risk level, indicating serious health effects or death.

Open source
Center-leftMostly Factual
QuartzNews report · Sep 24, 2:30 PM

FDA upgraded a recalled thyroid tablet to its most dangerous recall category

The FDA on Sept. 22 classified the recall of one lot of Vitruvias Therapeutics' 30 mg thyroid tablets as Class I, its highest risk level

Open source
RightMixed
The Epoch TimesNews report · Sep 24, 2:11 PM

FDA Raises Thyroid Tablet Recall to Most Serious Level Over Superpotency Issue

Several weeks ago, Vitruvias Therapeutics recalled one lot of thyroid tablets because of the potency issue.

Open source
Details0/99 Wording Gap · High confidence · 3 sources
0/99 Wording GapHigh confidence3 sources · 3 bias bucketsStable · 9 sources · all three buckets · comparable news formatFormats: News report

SOURCE MAP CHANGES

Sep 24, 2:11 PM: The Epoch Times joined the source map.

Sep 24, 2:30 PM: Quartz joined the source map.

Sep 24, 3:19 PM: WBIR10 (Tegna, Knoxville) joined the source map.

Now: Wording Gap is 0/99 and story health is stable · 9 sources · all three buckets · comparable news format.